Despite
broad application of nanotechnology in neuroscience, the
nanoneurotoxicity of magnetic nanoparticles in primary hippocampal
neurons remains poorly characterized. In particular, understanding
how magnetic nanoparticles perturb neuronal calcium homeostasis is
critical when considering magnetic nanoparticles as a nonviral vector
for effective gene therapy in neuronal diseases. Here, we address
the pressing need to systematically investigate the neurotoxicity
of magnetic nanoparticles with different surface charges in primary
hippocampal neurons. We found that unlike negative and neutral nanoparticles,
positively charged magnetic nanoparticles (magnetic poly(lactic-co-glycolic acid) (PLGA)-polyethylenimine (PEI) nanoparticles,
MNP-PLGA-PEI NPs) rapidly elevated cytoplasmic calcium levels in primary
hippocampal neurons, mainly via extracellular calcium influx regulated
by voltage-gated calcium channels. We went on to show that this perturbation
of intracellular calcium homeostasis elicited serious cytotoxicity
in primary hippocampal neurons. However, our next experiment demonstrated
that PEGylation on the surface of MNP-PLGA-PEI NPs shielded the surface
charge, thereby preventing the perturbation of intracellular calcium
homeostasis. That is, PEGylated MNP-PLGA-PEI NPs reduced nanoneurotoxicity.
Importantly, biocompatible PEGylated MNP-PLGA-PEI NPs under an external
magnetic field enhanced transfection efficiency (>7%) of plasmid
DNA
encoding GFP in primary hippocampal neurons compared to NPs without
external magnetic field mediation. Moreover, under an external magnetic
field, this system achieved gene transfection in the hippocampus of
the C57 mouse. Overall, this study is the first to successfully employ
biocompatible PEGylated MNP-PLGA-PEI NPs for transfection using a
magnetofection strategy in primary hippocampal neurons, thereby providing
a nanoplatform as a new perspective for treating neuronal diseases
or modulating neuron activities.